Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial

201630 citationsJournal Articlediamond Open Access

Authors

To investigate the efficacy of pegylated interferon alfa (PEG-IFN) therapy with and without entecavir in patients with chronic hepatitis D.

Good health and well-being

Published in: World Journal of Hepatology

Volume 8, Issue 14, pp. 625-625

Field-Weighted Citation Impact: 1.40